EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Multiplatform-Integrated Identification of Melatonin Targets for a Triad of Psychosocial-Sleep/Circadian-Cardiometabolic Disorders

Luciana Aparecida Campos iD, Ovidiu Constantin Baltatu iD, Sergio Senar iD, Rym Ghimouz, Eman Alefishat iD, José Cipolla-Neto iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24010860 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Luciana Aparecida Campos und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center of Innovation, Technology, and Education (CITE) at Anhembi Morumbi University-Anima Institute, Sao Jose dos Campos Technology Park, Sao Jose d…. Hauptthemen laut MEDLINE: Circadian Rhythm, Melatonin, Receptors, Melatonin, Sleep Wake Disorders. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: São Paulo Research Foundation, Sao Paulo Research Foundation (FAPESP), Anima Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Several psychosocial, sleep/circadian, and cardiometabolic disorders have intricately interconnected pathologies involving melatonin disruption. Therefore, we hypothesize that melatonin could be a therapeutic target for treating potential comorbid diseases associated with this triad of psychosocial-sleep/circadian-cardiometabolic disorders. We investigated melatonin’s target prediction and tractability for this triad of disorders. The melatonin’s target prediction for the proposed psychosocial-sleep/circadian-cardiometabolic disorder triad was investigated using databases from Europe PMC, ChEMBL, Open Targets Genetics, Phenodigm, and PheWAS. The association scores for melatonin receptors MT1 and MT2 with this disorder triad were explored for evidence of target–disease predictions. The potential of melatonin as a tractable target in managing the disorder triad was investigated using supervised machine learning to identify melatonin activities in cardiovascular, neuronal, and metabolic assays at the cell, tissue, and organism levels in a curated ChEMBL database. Target–disease visualization was done by graphs created using “igraph” library-based scripts and displayed using the Gephi ForceAtlas algorithm. The combined Europe PMC (data type: text mining), ChEMBL (data type: drugs), Open Targets Genetics Portal (data type: genetic associations), PhenoDigm (data type: animal models), and PheWAS (data type: genetic associations) databases yielded types and varying levels of evidence for melatonin-disease triad correlations. Of the investigated databases, 235 association scores of melatonin receptors with the targeted diseases were greater than 0.2; to classify the evidence per disease class: 37% listed psychosocial disorders, 9% sleep/circadian disorders, and 54% cardiometabolic disorders. Using supervised machine learning, 546 cardiovascular, neuronal, or metabolic experimental assays with predicted or measured melatonin activity scores were identified in the ChEMBL curated database. Of 248 registered trials, 144 phase I to IV trials for melatonin or agonists have been completed, of which 33.3% were for psychosocial disorders, 59.7% were for sleep/circadian disorders, and 6.9% were for cardiometabolic disorders. Melatonin’s druggability was evidenced by evaluating target prediction and tractability for the triad of psychosocial-sleep/circadian-cardiometabolic disorders. While melatonin research and development in sleep/circadian and psychosocial disorders is more advanced, as evidenced by melatonin association scores, substantial evidence on melatonin discovery in cardiovascular and metabolic disorders supports continued R&D in cardiometabolic disorders, as evidenced by melatonin activity scores. A multiplatform analysis provided an integrative assessment of the target–disease investigations that may justify further translational research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Circadian RhythmMelatoninReceptors, MelatoninSleep Wake DisordersMolecular Targeted TherapyMetabolic SyndromeAnimals

Stichwörter der Autor:innen

biomarkerscardiovascular disordersmachine learningpsychological stresssleep/circadian rhythm

Substanzen

MelatoninReceptors, Melatonin

Autor:innen und Institutionen

  • Center of Innovation, Technology, and Education (CITE) at Anhembi Morumbi University-Anima Institute, Sao Jose dos Campos Technology Park, Sao Jose dos Campos 12247-016, Brazil.
  • Department of Public Health and Epidemiology, College of Medicine and Health Science, Khalifa University, Abu Dhabi P.O. Box 127788, United Arab Emirates.
  • DrTarget, 28806 Madrid, Spain.
  • Fatima College of Health Sciences, Abu Dhabi P.O. Box 3798, United Arab Emirates.
  • Department of Pharmacology, College of Medicine and Health Science, Khalifa University, Abu Dhabi P.O. Box 127788, United Arab Emirates.
  • Department of Biopharmaceutics and Clinical Pharmacy, Faculty of Pharmacy, The University of Jordan, Amman 11942, Jordan.

ORCID-Profile: Luciana Aparecida Campos, Ovidiu Constantin Baltatu, Sergio Senar, Eman Alefishat, José Cipolla-Neto

Förderung

  • São Paulo Research Foundation
  • Sao Paulo Research Foundation (FAPESP)
  • Anima Institute
  • National Council for Scientific and Technological Development

Zitieren

APA

Campos, L. A., Baltatu, O. C., Senar, S., Ghimouz, R., Alefishat, E., & Cipolla-Neto, J. (2023). Multiplatform-Integrated Identification of Melatonin Targets for a Triad of Psychosocial-Sleep/Circadian-Cardiometabolic Disorders. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24010860

Vancouver

Campos LA, Baltatu OC, Senar S, Ghimouz R, Alefishat E, Cipolla-Neto J. Multiplatform-Integrated Identification of Melatonin Targets for a Triad of Psychosocial-Sleep/Circadian-Cardiometabolic Disorders. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24010860

BibTeX
@article{Campos2023,
  author = {Campos, Luciana Aparecida and Baltatu, Ovidiu Constantin and Senar, Sergio and Ghimouz, Rym and Alefishat, Eman and Cipolla-Neto, José},
  title = {Multiplatform-Integrated Identification of Melatonin Targets for a Triad of Psychosocial-Sleep/Circadian-Cardiometabolic Disorders},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24010860}
}
Kostenlos starten →